These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30592501)

  • 1. BRAF mutation: Current and future clinical pathological applications in colorectal carcinoma.
    Ng JY; Lu CT; Lam AK
    Histol Histopathol; 2019 May; 34(5):469-477. PubMed ID: 30592501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MLH1-deficient Colorectal Carcinoma With Wild-type BRAF and MLH1 Promoter Hypermethylation Harbor KRAS Mutations and Arise From Conventional Adenomas.
    Farchoukh L; Kuan SF; Dudley B; Brand R; Nikiforova M; Pai RK
    Am J Surg Pathol; 2016 Oct; 40(10):1390-9. PubMed ID: 27438990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both BRAF and KRAS mutations are rare in colorectal carcinomas from patients with hereditary nonpolyposis colorectal cancer.
    Miyaki M; Iijima T; Yamaguchi T; Kadofuku T; Funata N; Mori T
    Cancer Lett; 2004 Jul; 211(1):105-9. PubMed ID: 15194222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of BRAF V600E mutations in 969 central nervous system neoplasms.
    Behling F; Barrantes-Freer A; Skardelly M; Nieser M; Christians A; Stockhammer F; Rohde V; Tatagiba M; Hartmann C; Stadelmann C; Schittenhelm J
    Diagn Pathol; 2016 Jun; 11(1):55. PubMed ID: 27350555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal carcinomas with KRAS codon 12 mutation are associated with more advanced tumor stages.
    Li W; Qiu T; Zhi W; Shi S; Zou S; Ling Y; Shan L; Ying J; Lu N
    BMC Cancer; 2015 May; 15():340. PubMed ID: 25929517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic BRAF-V600E mutations in familial colorectal cancer.
    Vandrovcova J; Lagerstedt-Robinsson K; Påhlman L; Lindblom A
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2270-3. PubMed ID: 17119056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic features and treatment efficacy of Chinese patients with BRAF-mutated metastatic colorectal cancer: a retrospective observational study.
    Wang X; Wei Q; Gao J; Li J; Li J; Gong J; Li Y; Shen L
    Chin J Cancer; 2017 Oct; 36(1):81. PubMed ID: 29037218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].
    Zhang X; Wang Y; Gao N; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):77-82. PubMed ID: 24742565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRAF V600E mutation detection by immunohistochemistry in colorectal carcinoma.
    Affolter K; Samowitz W; Tripp S; Bronner MP
    Genes Chromosomes Cancer; 2013 Aug; 52(8):748-52. PubMed ID: 23650027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency.
    Dawson H; Galván JA; Helbling M; Muller DE; Karamitopoulou E; Koelzer VH; Economou M; Hammer C; Lugli A; Zlobec I
    Int J Cancer; 2014 May; 134(10):2342-51. PubMed ID: 24166180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRAF
    Dizdar L; Werner TA; Drusenheimer JC; Möhlendick B; Raba K; Boeck I; Anlauf M; Schott M; Göring W; Esposito I; Stoecklein NH; Knoefel WT; Krieg A
    Int J Cancer; 2019 Mar; 144(6):1379-1390. PubMed ID: 30144031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer.
    Deng G; Bell I; Crawley S; Gum J; Terdiman JP; Allen BA; Truta B; Sleisenger MH; Kim YS
    Clin Cancer Res; 2004 Jan; 10(1 Pt 1):191-5. PubMed ID: 14734469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AKT1 E17K in Colorectal Carcinoma Is Associated with BRAF V600E but Not MSI-H Status: A Clinicopathologic Comparison to PIK3CA Helical and Kinase Domain Mutants.
    Hechtman JF; Sadowska J; Huse JT; Borsu L; Yaeger R; Shia J; Vakiani E; Ladanyi M; Arcila ME
    Mol Cancer Res; 2015 Jun; 13(6):1003-8. PubMed ID: 25714871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer.
    Loughrey MB; Waring PM; Tan A; Trivett M; Kovalenko S; Beshay V; Young MA; McArthur G; Boussioutas A; Dobrovic A
    Fam Cancer; 2007; 6(3):301-10. PubMed ID: 17453358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRAF mutations in colorectal carcinoma suggest two entities of microsatellite-unstable tumors.
    Lubomierski N; Plotz G; Wormek M; Engels K; Kriener S; Trojan J; Jungling B; Zeuzem S; Raedle J
    Cancer; 2005 Sep; 104(5):952-61. PubMed ID: 16015629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer.
    Oliveira C; Velho S; Domingo E; Preto A; Hofstra RM; Hamelin R; Yamamoto H; Seruca R; Schwartz S
    Oncogene; 2005 Nov; 24(51):7630-4. PubMed ID: 16007118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer.
    Seth R; Crook S; Ibrahem S; Fadhil W; Jackson D; Ilyas M
    Gut; 2009 Sep; 58(9):1234-41. PubMed ID: 19474002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRAF mutations in sporadic colorectal carcinoma from polish patients.
    Wójcik P; Okoń K; Osuch C; Klimkowska A; Tomaszewska R
    Pol J Pathol; 2010; 61(1):23-6. PubMed ID: 20496269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRAF mutations in aberrant crypt foci and hyperplastic polyposis.
    Beach R; Chan AO; Wu TT; White JA; Morris JS; Lunagomez S; Broaddus RR; Issa JP; Hamilton SR; Rashid A
    Am J Pathol; 2005 Apr; 166(4):1069-75. PubMed ID: 15793287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRAF mutation as a potential marker to identify the proximal colon serrated polyps with malignant potential.
    Fu X; Zhang X
    Int J Clin Exp Pathol; 2014; 7(11):7319-22. PubMed ID: 25550768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.